Klaus Korn
- Infectious Diseases top 1%
- Virology top 0.5%
- Epidemiology top 5%
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 5%
- Co-authors
- Bárbara SchmidtHauke WalterUlrike KämmererRolf KaiserKlaus ÜberlaDaniel HoffmannNiko BeerenwinkelJoachim Selbig
- Topics
- HIV Research and Treatment (38 papers)HIV/AIDS drug development and treatment (34 papers)HIV/AIDS Research and Interventions (18 papers)
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesJournal of Biological Chemistry
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Klaus Korn
104 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 135
- Infectious Diseases 1.3k
- Virology 818
- Epidemiology 693
- Molecular Biology 418
- Cardiology and Cardiovascular Medicine 328
Countries citing papers authored by Klaus Korn
This map shows the geographic impact of Klaus Korn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Korn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Korn more than expected).
Fields of papers citing papers by Klaus Korn
This network shows the impact of papers produced by Klaus Korn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Korn. The network helps show where Klaus Korn may publish in the future.
Co-authorship network of co-authors of Klaus Korn
This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Korn. A scholar is included among the top collaborators of Klaus Korn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Korn. Klaus Korn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 34 | |
| 7 | 23 | |
| 8 | 42 | |
| 9 | 26 | |
| 10 | 26 | |
| 11 | 13 | |
| 12 | 25 | |
| 13 | 31 | |
| 14 | Safety and efficacy of a NRTI sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1 infected children. | 1 |
| 15 | The drug resistance profile of tenofovir: a story of resistance and resensitization | 1 |
| 16 | Determination of the optimal cut-offs for predicting the phenotype of nine different HIV drug-resistance algorithms | 1 |
| 17 | 3 | |
| 18 | Identifying drug resistance-associated patterns in HIV genotypes | 1 |
| 19 | 74 | |
| 20 | 21 |
About Klaus Korn
Klaus Korn is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 107 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (38 papers), HIV/AIDS drug development and treatment (34 papers) and HIV/AIDS Research and Interventions (18 papers). The work is most often cited by research in Virology (818 citations), Infectious Diseases (1.3k citations) and Hepatology (178 citations). Klaus Korn has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Bárbara Schmidt, Hauke Walter, Ulrike Kämmerer, Rolf Kaiser, Klaus Überla, Daniel Hoffmann, Niko Beerenwinkel, Joachim Selbig, Thomas Lengauer and Benedikt Weißbrich. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.